Premium
A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 G Y INVOLVED‐SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK H ODGKIN LYMPHOMA
Author(s) -
Kumar A.,
Casulo C.,
Advani R.,
Budde E.,
Barr P.M.,
Batlevi C.L.,
Chen R.,
Constine L.S.,
Courtien A.I.,
Dandapani S.V.,
Drullinsky P.,
Friedberg J.W.,
Hamlin P.A.,
Hoppe R.T.,
Matasar M.J.,
McArthur G.N.,
Miller S.T.,
Moskowitz A.J.,
Noy A.,
Schoder H.,
Straus D.J.,
Yang J.,
Younes A.,
Zelenetz A.D.,
Yahalom J.,
Moskowitz C.H.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_30
Subject(s) - medicine , cohort , radiation therapy , chemotherapy , stage (stratigraphy) , oncology , gastroenterology , surgery , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom